Ted Mikuls
Overview
Explore the profile of Ted Mikuls including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
1158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Buch M, Bhatt D, Charles-Schoeman C, Giles J, Mikuls T, Koch G, et al.
RMD Open
. 2024 Apr;
10(2).
PMID: 38609322
Objectives: Compare the risk of extended major adverse cardiovascular (CV) event (MACE) composite outcomes and component events in patients with rheumatoid arthritis (RA) treated with tofacitinib versus tumour necrosis factor...
2.
Sanchez C, Campeau A, Liu-Bryan R, Mikuls T, ODell J, Gonzalez D, et al.
Res Sq
. 2024 Jan;
PMID: 38260556
Background: Effective xanthine oxidoreductase inhibition (XOI) urate-lowering treatment (ULT) to target significantly reduces gout flare burden and synovitis between 1-2 years therapy, without clearing all monosodium urate crystal deposits. Paradoxically,...
3.
Ledbetter S, Xie F, Cutter G, Saag K, Jackson L, Danila M, et al.
Arthritis Rheumatol
. 2022 Mar;
74(6):1091-1092.
PMID: 35235715
No abstract available.
4.
FitzGerald J, Brignardello R, Dalbeth N, Mikuls T, Neogi T, Guyatt G
Arthritis Care Res (Hoboken)
. 2020 Jul;
72(10):1507-1508.
PMID: 32702200
No abstract available.
5.
FitzGerald J, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles A, et al.
Arthritis Care Res (Hoboken)
. 2020 May;
72(6):744-760.
PMID: 32391934
Objective: To provide guidance for the management of gout, including indications for and optimal use of urate-lowering therapy (ULT), treatment of gout flares, and lifestyle and other medication recommendations. Methods:...
6.
FitzGerald J, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles A, et al.
Arthritis Rheumatol
. 2020 May;
72(6):879-895.
PMID: 32390306
Objective: To provide guidance for the management of gout, including indications for and optimal use of urate-lowering therapy (ULT), treatment of gout flares, and lifestyle and other medication recommendations. Methods:...
7.
Mehta B, Pedro S, Ozen G, Kalil A, Wolfe F, Mikuls T, et al.
RMD Open
. 2019 Jun;
5(1):e000935.
PMID: 31245055
Objectives: To identify serious infection (SI) risk by aetiology and site in patients with rheumatoid arthritis (RA) compared with those with non-inflammatory rheumatic and musculoskeletal diseases (NIRMD). Methods: Patients participating...
8.
Goodman S, Springer B, Guyatt G, Abdel M, Dasa V, George M, et al.
J Arthroplasty
. 2017 Jun;
32(9):2628-2638.
PMID: 28629905
Objective: This collaboration between the American College of Rheumatology and the American Association of Hip and Knee Surgeons developed an evidence-based guideline for the perioperative management of antirheumatic drug therapy...
9.
Goodman S, Springer B, Guyatt G, Abdel M, Dasa V, George M, et al.
Arthritis Rheumatol
. 2017 Jun;
69(8):1538-1551.
PMID: 28620948
Objective: This collaboration between the American College of Rheumatology and the American Association of Hip and Knee Surgeons developed an evidence-based guideline for the perioperative management of antirheumatic drug therapy...
10.
Goodman S, Springer B, Guyatt G, Abdel M, Dasa V, George M, et al.
Arthritis Care Res (Hoboken)
. 2017 Jun;
69(8):1111-1124.
PMID: 28620917
Objective: This collaboration between the American College of Rheumatology and the American Association of Hip and Knee Surgeons developed an evidence-based guideline for the perioperative management of antirheumatic drug therapy...